Bisoprolol Fumarate

Bisoprolol Fumarate

Nome del prodotto Bisoprolol Fumarate
Numero CAS 104344-23-2
Formula molecolare C18H31NO4 · ½ C4H4O4
Peso molecolare 766.96 g/mol (as fumarate salt)
Aspetto Polvere cristallina di colore da bianco a bianco sporco
Analisi (HPLC) 98.0% – 102.0% (on dried basis)
Perdita per essiccazione ≤ 0,51 TP3T
Residuo di combustione ≤ 0,11 TP3T
Metalli pesanti ≤ 10 ppm
Solubilità Sparingly soluble in water, freely soluble in methanol, slightly soluble in ethanol
Confezione 25 kg net in fiber drum with double polyethylene liner

Hai bisogno di aiuto? Contatta il nostro team

Bisoprolol Fumarate Structure

Sinonimi: Bisoprolol fumarate, 104344-23-2, EMD 33512, Bisoce, Bisoprolol hemifumarate, (±)-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol fumarate

Bisoprolol fumarate is a synthetic, cardioselective beta-1 adrenergic receptor blocker belonging to the aminoxypropanol class. It is supplied as a white to off-white crystalline powder, manufactured under cGMP conditions and tested to meet or exceed current pharmacopoeial standards (USP/EP).

As a highly selective beta-1 antagonist, bisoprolol fumarate is a cornerstone API for the treatment of hypertension, chronic stable angina, and heart failure. Its balanced lipophilicity and long half-life make it suitable for once-daily dosing, and it remains a preferred choice among healthcare professionals for cardiovascular management.

Product Highlights

  • High purity: ≥98.0% assay, with tight control on related substances and residual solvents.
  • Regulatory support: Available with DMF (Type II) and CEP, suitable for ANDA and generic filings.
  • Stable supply: Commercial-scale production with a current capacity of 20 metric tons per year.
  • Quality assurance: Each batch is fully traceable, with full documentation and retained samples.
  • Competitive pricing: Direct from manufacturer, offering cost advantages for bulk orders.

Applicazioni

  • Treatment of essential hypertension, either as monotherapy or in combination with other antihypertensives.
  • Management of chronic stable angina pectoris.
  • Adjunct therapy in stable chronic heart failure with reduced ejection fraction.
  • Formulation of immediate-release and fixed-dose combination tablets.
  • Research on beta-adrenergic receptor pharmacology and cardiovascular therapeutics.

Caratteristiche tecniche

Parametro Specifiche
Assay (HPLC, dried basis) 98.0% – 102.0%
Aspetto Polvere cristallina di colore da bianco a bianco sporco
Identificazione I tempi di ritenzione IR, UV e HPLC corrispondono allo standard di riferimento
Perdita per essiccazione ≤ 0,51 TP3T
Residuo di combustione ≤ 0,11 TP3T
Metalli pesanti ≤ 10 ppm
Sostanze correlate Each impurity ≤ 0.5%, total ≤ 1.0%

Ordering & Supply

  • Confezionamento: 25 kg net in fiber drum with double polyethylene liner; custom packaging available upon request.
  • MOQ: 1 kg for trial orders; 25 kg for commercial orders.
  • Tempi di consegna: 3-5 business days (stock items)
  • Documentazione: COA, MSDS, TDS, and regulatory support (DMF, CEP) provided with each shipment.

Richiesta di preventivo

RIMANI IN CONTATTO

Richiesta di preventivo

Il nostro indirizzo

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×